Meeting
2024 ASCO Gastrointestinal Cancers Symposium
New cutoff of CA19-9 values for predicting pancreatic cancer using liquid biopsy.
Authors
Ryuji Hasebe
Jichi Medical University, Saitama Medical Center, Saitama-Shi Omiya-Ku, Japan
Ryuji Hasebe , Fumiaki Watanabe , Koichi Suzuki , Toshiki Rikiyama
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 692)
DOI
10.1200/JCO.2024.42.3_suppl.692
Abstract #
692
Poster Bd #
N1
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
KRAS mutations allelic frequency dynamics using plasma extracellular vesicles: Association with survival outcomes in localized pancreatic adenocarcinoma.
First Author: Asmita Chopra
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The utility of PD-L1 as a prognostic marker in pancreatic ductal adenocarcinoma (PDAC).
First Author: Linda Wu
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Molecular precision medicine in pancreatic cancer: A single-center experience.
First Author: Anthony Tarabay
Poster
2021 Gastrointestinal Cancers Symposium
The use of elevated circulating hepatocyte growth factor (HGF) level as a potential prognostic biomarker in locally advanced pancreatic cancer.
First Author: Hannah Johnson Roberts